18F-Radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals

Nuclear Medicine Communications

Volumn 34, Issue 7, 2013, Pages 701-708

  Wu, Haifei ^a   Liang, Sheng ^a   Liu, Shuai ^a   Pan, Yu ^a   Cheng, Dengfeng ^b   Zhang, Yifan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

18F; Glucagon like peptide 1 analog; Insulinoma; Micro PET CT; Molecular imaging

Indexed keywords

EXENDIN 4; FB EXENDIN 4 F 18; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; IODINE 125; RADIOPHARMACEUTICAL AGENT; SUCCINIMIDYL 4 FLUOROBENZOATE F 18; UNCLASSIFIED DRUG; BENZOIC ACID DERIVATIVE; FLUORINE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; N-SUCCINIMIDYL-4-FLUOROBENZOATE; PEPTIDE; SUCCINIMIDE DERIVATIVE; VENOM; DIAGNOSTIC AGENT; N SUCCINIMIDYL 4 FLUOROBENZOATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG CONJUGATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INSULINOMA; MOUSE; NONHUMAN; RADIOACTIVITY; RADIOCHEMISTRY; ANIMAL; BINDING COMPETITION; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; FEMALE; ISOTOPE LABELING; METABOLISM; MULTIMODAL IMAGING; PANCREATIC NEOPLASMS; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; SCINTISCANNING; METHODOLOGY; PANCREAS TUMOR;

ANIMALS; BENZOATES; BINDING, COMPETITIVE; FEMALE; FLUORINE RADIOISOTOPES; GLUCAGON-LIKE PEPTIDE 1; INSULINOMA; ISOTOPE LABELING; MICE; MULTIMODAL IMAGING; PANCREATIC NEOPLASMS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RECEPTORS, GLUCAGON; SUCCINIMIDES; TOMOGRAPHY, X-RAY COMPUTED; VENOMS;

EID: 84879886408     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283614187     Document Type: Article

References (22)

1. Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997; 112: 583-590.
2. Bhate K, Mok WY, Tran K, Khan S, Al-Nahhas A. Functional assessment in the multimodality imaging of pancreatic neuro-endocrine tumours. Minerva Endocrinol 2010; 35: 17-25.
3. Rockall AG, Reznek RH. Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab 2007; 21: 43-68.
4. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med 1996; 125: 26-34.
5. Reubi JC,Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 2003; 30: 781-793.
6. Lankat-Buttgereit B, Göke R, Stöckmann F, Jiang J, Fehmann HC, Göke B. Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes. Digestion 1994; 55: 29-33.
7. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 1992; 267: 7402-7405.
8. Deacon CF, Knudsen LB, Madsen K, Wiberg FC, Jacobsen O, Holst JJ. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity. Diabetologia 1998; 41: 271-278.
9. López de Maturana R, Willshaw A, Kuntzsch A, Rudolph R, Donnelly D. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1. J Biol Chem 2003; 278: 10195-10200.
10. Wild D, Béhé M, Wicki A, Storch D, Waser B, Gotthardt M. [Lys40 (Ahx- DTPA-111In) NH2] exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. J Nucl Med 2006; 47: 2025-2033.
11. Wild D, Wicki A, Mansi R, Béhé M, Keil B, Bernhardt P. Exendin-4-based radiopharmaceuticals for glucagon-like peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med 2010; 51: 1059-1067.
12. Kiesewetter DO, Gao H, Ma Y, Niu G, Quan Q, Guo N, et al. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma. Eur J Nucl Med Mol Imaging 2012; 39: 463-473.
13. Wang Y, Lim K, Normandin M, Zhao X, Cline GW, Ding YS. Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic b-cell mass. Nucl Med Biol 2012; 39: 167-176.
14. Butler SR, Lam RW, Fisher DA. Iodination of thyroliberin by use of Iodogen. Clin Chem 1984; 30: 547-548.
15. Richardson AP, Mountford PJ, Baird AC, Heyderman E, Richardson TC, Coakley AJ. An improved iodogen method of labelling antibodies with 123I. Nucl Med Commun 1986; 7: 355-362.
16. Thonon D, Goblet D, Goukens E, Kaisin G, Paris J, Aerts J. Fully automated preparation and conjugation of N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) with RGD peptide using a GE FASTlab synthesizer. Mol Imaging Biol 2011; 13: 1088-1095.
17. Vaidyanathan G, Zalutsky MR. Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F. Nat Protoc 2006; 1: 1655-1661.
18. Toretsky J, Levenson A,Weinberg IN, Tait JF, Uren A, Mease RC. Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl Med Biol 2004; 31: 747-752.
19. Gotthardt M, Fischer M, Naeher I, Holz JB, Jungclas H, Fritsch HW. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results. Eur J Nucl Med Mol Imaging 2002; 29: 597-606.
20. Korner M, Stockli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 2007; 48: 736-743.
21. Wild D, Macke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med 2008; 359: 766-768.
22. Pattou F, Kerr-Conte J, Wild D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle. N Engl J Med 2010; 363:1289-1290.